Public Policy Resources

Share

State Biomarker Coverage Laws

July 27, 2026

Advancements in biomarker testing have transformed cancer treatment, improving survival and quality of life by connecting patients with the therapies most likely to benefit them, and coverage of these tests is essential to ensuring access to precision treatments.

This white paper highlights the importance of state biomarker coverage laws and offers recommendations to expand access to testing.

PDF icon Download the white paper.

Related Resources

Equidad en salud en las pruebas de biomarcadores y terapias dirigidas

February 15, 2024

La terapia dirigida puede mejorar la supervivencia y la calidad de vida al conectar a los pacientes con el tratamiento más beneficioso para su enfermedad.

Read more

Cancer Patients and Survivors Overwhelmingly Agree Biomarker Testing Improved Their Treatment

October 19, 2023

Our latest Survivor Views survey sees increases in biomarker testing since the question was last asked three years ago along with reduced cost and coverage barriers in that time. Cancer patients and survivors describe the benefits and overwhelmingly agree biomarker testing gave their providers information that improved their treatment. 

Read more